Carta científico-clínica
Paniculitis mixta secundaria al uso de interferón β 1A en una paciente con esclerosis múltiple
Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis
Leído
9254
Vecesse ha leído el artículo
2630
Total PDF
6624
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 10 | 6 | 16 |
| 2025 5 | 73 | 25 | 98 |
| 2025 4 | 84 | 32 | 116 |
| 2025 3 | 93 | 12 | 105 |
| 2025 2 | 71 | 27 | 98 |
| 2025 1 | 66 | 27 | 93 |
| 2024 12 | 44 | 20 | 64 |
| 2024 11 | 63 | 52 | 115 |
| 2024 10 | 42 | 37 | 79 |
| 2024 9 | 45 | 20 | 65 |
| 2024 8 | 73 | 52 | 125 |
| 2024 7 | 69 | 31 | 100 |
| 2024 6 | 78 | 34 | 112 |
| 2024 5 | 52 | 31 | 83 |
| 2024 4 | 71 | 32 | 103 |
| 2024 3 | 48 | 24 | 72 |
| 2024 2 | 42 | 30 | 72 |
| 2024 1 | 55 | 22 | 77 |
| 2023 12 | 63 | 19 | 82 |
| 2023 11 | 79 | 23 | 102 |
| 2023 10 | 70 | 19 | 89 |
| 2023 9 | 64 | 16 | 80 |
| 2023 8 | 55 | 23 | 78 |
| 2023 7 | 75 | 41 | 116 |
| 2023 6 | 77 | 24 | 101 |
| 2023 5 | 52 | 12 | 64 |
| 2023 4 | 40 | 22 | 62 |
| 2023 3 | 86 | 19 | 105 |
| 2023 2 | 77 | 22 | 99 |
| 2022 1 | 47 | 26 | 73 |
| 2022 12 | 55 | 26 | 81 |
| 2022 11 | 56 | 36 | 92 |
| 2022 10 | 60 | 45 | 105 |
| 2022 9 | 66 | 50 | 116 |
| 2022 8 | 61 | 59 | 120 |
| 2022 7 | 58 | 48 | 106 |
| 2022 6 | 58 | 28 | 86 |
| 2022 5 | 67 | 27 | 94 |
| 2022 4 | 54 | 25 | 79 |
| 2022 3 | 43 | 50 | 93 |
| 2022 2 | 44 | 26 | 70 |
| 2021 1 | 53 | 46 | 99 |
| 2021 12 | 35 | 42 | 77 |
| 2021 11 | 43 | 39 | 82 |
| 2021 10 | 75 | 42 | 117 |
| 2021 9 | 48 | 46 | 94 |
| 2021 8 | 54 | 30 | 84 |
| 2021 7 | 44 | 39 | 83 |
| 2021 6 | 51 | 33 | 84 |
| 2021 5 | 40 | 29 | 69 |
| 2021 4 | 71 | 68 | 139 |
| 2021 3 | 67 | 32 | 99 |
| 2021 2 | 47 | 28 | 75 |
| 2020 1 | 30 | 20 | 50 |
| 2020 12 | 34 | 18 | 52 |
| 2020 11 | 9 | 17 | 26 |
| 2020 10 | 42 | 16 | 58 |
| 2020 9 | 28 | 17 | 45 |
| 2020 8 | 21 | 26 | 47 |
| 2020 7 | 34 | 19 | 53 |
| 2020 6 | 30 | 20 | 50 |
| 2020 5 | 21 | 36 | 57 |
| 2020 4 | 31 | 27 | 58 |
| 2020 3 | 25 | 18 | 43 |
| 2020 2 | 6 | 4 | 10 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 4 | 4 | 8 |
| 2019 11 | 2 | 2 | 4 |
| 2019 9 | 6 | 14 | 20 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 0 | 7 | 7 |
| 2019 6 | 2 | 15 | 17 |
| 2019 5 | 1 | 3 | 4 |
| 2019 4 | 0 | 2 | 2 |
| 2019 3 | 2 | 6 | 8 |
| 2019 2 | 2 | 1 | 3 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 1 | 2 | 3 |
| 2018 10 | 2 | 2 | 4 |
| 2018 9 | 5 | 1 | 6 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 11 | 11 |
| 2018 3 | 3 | 0 | 3 |
| 2018 2 | 68 | 4 | 72 |
| 2018 1 | 65 | 8 | 73 |
| 2017 12 | 96 | 11 | 107 |
| 2017 11 | 73 | 9 | 82 |
| 2017 10 | 63 | 13 | 76 |
| 2017 9 | 80 | 26 | 106 |
| 2017 8 | 77 | 13 | 90 |
| 2017 7 | 49 | 14 | 63 |
| 2017 6 | 85 | 19 | 104 |
| 2017 5 | 108 | 21 | 129 |
| 2017 4 | 50 | 12 | 62 |
| 2017 3 | 84 | 28 | 112 |
| 2017 2 | 117 | 10 | 127 |
| 2016 1 | 48 | 19 | 67 |
| 2016 12 | 91 | 5 | 96 |
| 2016 11 | 115 | 11 | 126 |
| 2016 10 | 119 | 25 | 144 |
| 2016 9 | 214 | 22 | 236 |
| 2016 8 | 186 | 10 | 196 |
| 2016 7 | 82 | 13 | 95 |
| 2016 6 | 6 | 15 | 21 |
| 2016 5 | 7 | 10 | 17 |
| 2016 4 | 4 | 4 | 8 |
| 2016 3 | 3 | 2 | 5 |
| 2016 2 | 8 | 3 | 11 |
| 2015 1 | 5 | 25 | 30 |
| 2015 12 | 9 | 16 | 25 |
| 2015 11 | 7 | 16 | 23 |
| 2015 10 | 9 | 14 | 23 |
| 2015 9 | 4 | 8 | 12 |
| 2015 8 | 11 | 9 | 20 |
| 2015 7 | 177 | 2 | 179 |
| 2015 6 | 109 | 8 | 117 |
| 2015 5 | 94 | 26 | 120 |
| 2015 4 | 76 | 19 | 95 |
| 2015 3 | 26 | 9 | 35 |
| 2015 2 | 29 | 10 | 39 |
| 2015 1 | 33 | 8 | 41 |
| 2014 12 | 44 | 6 | 50 |
| 2014 11 | 44 | 9 | 53 |
| 2014 10 | 61 | 3 | 64 |
| 2014 9 | 39 | 9 | 48 |
| 2014 8 | 50 | 10 | 60 |
| 2014 7 | 33 | 4 | 37 |
| 2014 6 | 44 | 6 | 50 |
| 2014 5 | 46 | 11 | 57 |
| 2014 4 | 41 | 3 | 44 |
| 2014 3 | 56 | 6 | 62 |
| 2014 2 | 29 | 7 | 36 |
| 2014 1 | 24 | 10 | 34 |
| 2013 12 | 37 | 18 | 55 |
| 2013 11 | 14 | 6 | 20 |
| 2013 10 | 25 | 9 | 34 |
| 2013 9 | 20 | 12 | 32 |
| 2013 8 | 15 | 6 | 21 |
| 2013 7 | 19 | 0 | 19 |
| 2013 6 | 11 | 0 | 11 |
| 2013 5 | 18 | 2 | 20 |
| 2013 4 | 10 | 7 | 17 |
Mostrar todo
